Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Sectra AB (publ) (SECT-B.ST)
Linköping, SE
Sectra AB (publ), a Swedish company established in Linköping in 1957, specializes in providing advanced information technology solutions for both the medical and cybersecurity fields. Its services are predominantly offered across Europe, including key markets such as Sweden, the United Kingdom, and the Netherlands. The company's operations are structured into three primary divisions: Imaging IT Solutions, Secure Communications, and Business Innovation. The Imaging IT Solutions segment is responsible for creating and deploying medical IT systems and support services. These offerings are designed to efficiently manage, archive, and present various types of medical images and patient data, while also facilitating operational oversight and monitoring radiation exposure. This division further provides comprehensive maintenance, encompassing technical assistance and system surveillance, alongside expert consulting for integration, system architecture, data migration, and strategic business growth. Through its Secure Communications segment, Sectra engineers and supplies robust products and services aimed at ensuring secure voice and data exchanges, thereby protecting vital IT infrastructure. Beyond bespoke project development, this unit offers in-depth security and threat assessments, coupled with monitoring services for critical control systems. Finally, the Business Innovation segment focuses on pioneering and commercializing IT systems specifically tailored for the planning and supervision of orthopedic surgical procedures, in addition to developing educational tools and products for medical research initiatives. Sectra's diverse clientele includes both public and private healthcare providers, ranging from individual hospitals to extensive clinic networks, as well as governmental organizations, national defense departments, and companies operating within the energy sector.
Based on only 2 articles — low confidence
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.21% | +5.02% | +10.48% | +38.21% | +6.70% | +22.29% | -16.76% | +58.89% | +143.88% | +1,234.85% | +886.20% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | +1 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Devices: +11.2%+9.3% Q2'26: +13.0% (vs Q2'25)
-
EPS growth Medical - Devices: +28.5%+0.3% Q2'26: +20.6% (vs Q2'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%+24.1% Q2'26: +46.5% (vs Q2'25)
-
EBIT margin Medical - Devices: +6.2%+18.7% ★ Q2'26: +19.3% (vs Q2'25)
-
ROIC Medical - Devices: +3.3%+126.7% ★ Q2'26: +140.3% (vs Q2'25)
-
Share dilution Medical - Devices: 0.0%+0.0% ★ Q2'26: +0.0% (vs Q2'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×0.10× ★ Q2'26: 0.09× (vs Q2'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Apr 2015 actual |
Apr 2016 actual |
Apr 2017 actual |
Apr 2018 actual |
Apr 2019 actual |
Apr 2020 actual |
Apr 2021 actual |
Apr 2022 actual |
Apr 2023 actual |
Apr 2024 actual |
Apr 2025 actual |
Apr 2026 3 Rev. Ana. 3 EPS Ana. |
Apr 2027 1 Rev. Ana. 1 EPS Ana. |
Apr 2028 2 Rev. Ana. 2 EPS Ana. |
Apr 2029 1 Rev. Ana. 1 EPS Ana. |
Apr 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
961.39M
est: 1.08B (-10.7%)
|
1.07B
est: 1.06B (+1.2%)
|
1.14B
est: 1.14B (+0.3%)
|
1.27B
est: 1.28B (-0.8%)
|
1.41B
est: 1.40B (+1.1%)
|
1.66B
est: 1.66B (0.0%)
|
1.63B
est: 1.65B (-1.1%)
|
1.95B
est: 1.91B (+2.0%)
|
2.35B
est: 2.33B (+0.9%)
|
2.96B
est: 3.17B (-6.5%)
|
3.24B
est: 3.23B (+0.2%)
|
3.23B
3.22B – 3.26B
+0.0% YoY
|
3.81B
3.80B – 3.82B
+17.8% YoY
|
4.50B
4.48B – 4.53B
+18.1% YoY
|
5.52B
5.51B – 5.54B
+22.7% YoY
|
6.57B
6.54B – 6.59B
+18.8% YoY
|
| EBITDA |
193.61M
est: 256.07M (-24.4%)
|
207.66M
est: 252.52M (-17.8%)
|
271.88M
est: 270.64M (+0.5%)
|
272.56M
est: 303.93M (-10.3%)
|
255.06M
est: 332.60M (-23.3%)
|
349.57M
est: 395.43M (-11.6%)
|
429.01M
est: 392.87M (+9.2%)
|
477.28M
est: 454.74M (+5.0%)
|
538.55M
est: 554.54M (-2.9%)
|
615.06M
est: 718.99M (-14.5%)
|
795.35M
est: 733.14M (+8.5%)
|
733.50M
729.95M – 738.49M
+0.0% YoY
|
864.20M
861.48M – 866.92M
+17.8% YoY
|
1.02B
1.02B – 1.03B
+18.1% YoY
|
1.25B
1.25B – 1.26B
+22.7% YoY
|
1.49B
1.48B – 1.49B
+18.8% YoY
|
| EBIT |
165.80M
est: 222.88M (-25.6%)
|
156.16M
est: 219.80M (-29.0%)
|
201.30M
est: 235.56M (-14.5%)
|
232.64M
est: 264.54M (-12.1%)
|
250.04M
est: 289.50M (-13.6%)
|
305.79M
est: 344.18M (-11.2%)
|
350.09M
est: 341.95M (+2.4%)
|
396.06M
est: 395.80M (+0.1%)
|
481.45M
est: 482.67M (-0.3%)
|
556.06M
est: 639.30M (-13.0%)
|
730.59M
est: 651.88M (+12.1%)
|
652.20M
649.04M – 656.63M
+0.0% YoY
|
768.41M
765.99M – 770.83M
+17.8% YoY
|
907.81M
902.53M – 913.08M
+18.1% YoY
|
1.11B
1.11B – 1.12B
+22.7% YoY
|
1.32B
1.32B – 1.33B
+18.8% YoY
|
| Net Income |
126.08M
est: 135.78M (-7.1%)
|
125.70M
est: 115.53M (+8.8%)
|
152.79M
est: 135.48M (+12.8%)
|
198.26M
est: 169.58M (+16.9%)
|
198.98M
est: 180.83M (+10.0%)
|
237.35M
est: 222.45M (+6.7%)
|
275.51M
est: 243.74M (+13.0%)
|
314.79M
est: 315.33M (-0.2%)
|
374.96M
est: 342.53M (+9.5%)
|
428.39M
est: 447.23M (-4.2%)
|
563.37M
est: 565.19M (-0.3%)
|
563.78M
559.71M – 653.63M
-0.2% YoY
|
708.33M
705.43M – 711.23M
+25.6% YoY
|
891.50M
823.46M – 972.65M
+25.9% YoY
|
1.15B
1.14B – 1.15B
+28.4% YoY
|
1.50B
1.50B – 1.51B
+31.4% YoY
|
| SGA |
172.72M
est: 138.54M (+24.7%)
|
218.19M
est: 136.63M (+59.7%)
|
205.25M
est: 146.43M (+40.2%)
|
222.44M
est: 164.44M (+35.3%)
|
240.58M
est: 179.95M (+33.7%)
|
276.98M
est: 213.95M (+29.5%)
|
199.97M
est: 212.56M (-5.9%)
|
298.89M
est: 246.04M (+21.5%)
|
428.18M
est: 300.03M (+42.7%)
|
550.50M
est: 330.49M (+66.6%)
|
—
est: 336.99M (-100.0%)
|
337.16M
335.53M – 339.45M
+0.0% YoY
|
397.23M
395.98M – 398.48M
+17.8% YoY
|
469.30M
466.57M – 472.02M
+18.1% YoY
|
575.97M
574.15M – 577.78M
+22.7% YoY
|
684.39M
682.23M – 686.54M
+18.8% YoY
|
| EPS |
0.68
est: 0.70 (-3.5%)
|
0.67
est: 0.60 (+11.7%)
|
0.81
est: 0.70 (+15.2%)
|
1.04
est: 0.88 (+18.2%)
|
1.04
est: 0.94 (+10.8%)
|
1.24
est: 1.15 (+7.4%)
|
1.43
est: 1.27 (+13.0%)
|
1.63
est: 1.64 (-0.4%)
|
1.95
est: 1.78 (+9.7%)
|
2.22
est: 2.32 (-4.4%)
|
2.92
est: 2.93 (-0.5%)
|
3.08
2.91 – 3.39
+4.9% YoY
|
3.68
3.66 – 3.69
+19.5% YoY
|
4.66
4.27 – 5.05
+26.8% YoY
|
5.94
5.92 – 5.97
+27.5% YoY
|
7.81
7.78 – 7.84
+31.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-05 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-04 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-03 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-02 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-01 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-29 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-28 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-27 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-26 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-25 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-22 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-21 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-20 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-19 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares STOXX Europe Small 200 UCITS ETF (DE) EXSE.DE | 0.57% | 3.89M | 0.20% |
| 2 | iShares Healthcare Innovation UCITS ETF HEAL.L | 0.48% | 5.53M | 0.40% |
| 3 | iShares OMX Stockholm Capped UCITS ETF OM3X.DE | 0.43% | 929.5K | 0.10% |
| 4 | iShares MSCI Europe Small-Cap ETF IEUS | 0.24% | 426.9K | 0.41% |
| 5 | Xtrackers MSCI Europe Small Cap UCITS ETF 1C XXSC.L | 0.23% | 7.94M | 0.30% |
| 6 | Fidelity International High Quality ETF FCIQ.TO | 0.23% | 2.97M | 0.51% |
| 7 | iShares STOXX Europe 600 Health Care UCITS ETF (DE) EXV4.DE | 0.22% | 1.83M | 0.46% |
| 8 | Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Acc CEM.PA | 0.22% | 744.0K | 0.23% |
| 9 | Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Dist X026.DE | 0.22% | 744.0K | 0.23% |
| 10 | UBS MSCI World Small Cap Socially Responsible UCITS ETF USD acc WSCSRI.SW | 0.15% | 1.18M | 0.23% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Torbjörn Kronander | President, Chief Executive Officer & Director | 8M | — |
| Helena Pettersson | Chief Investor Relations Officer | — | female |
| Ingemar Ingemarsson | Founder | — | male |
| Jessica Holmquist | Chief Financial Officer | — | female |
| Lisa Everhill | Chief People & Brand Officer | — | female |
| Marie Ekstrom Tragardh | President of Imaging IT Solutions Operating Area, Executive Vice President & Head of Product Area Radiology | — | female |
| Per Andersnäs | Chief Information Officer | — | male |
| Robert Forchheimer | Founder | — | male |
| Fredrik Gustavsson | Chief Technology Officer | — | — |
| Viiveke Fåk | Founder | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SECT-B.ST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
